Dunlay S.M. Roger V.L. Redfield M.M.

Epidemiology of heart failure with preserved ejection fraction.

Nat Rev Cardiol. 14: 591-602Obokata M. Reddy Y.N.V. Borlaug B.A.

Diastolic dysfunction and heart failure with preserved ejection fraction: understanding mechanisms by using noninvasive methods.

JACC Cardiovasc Imaging. 13: 245-257Chirinos J.A. Orlenko A. Zhao L. et al.

Multiple plasma biomarkers for risk stratification in patients with heart failure and preserved ejection fraction.

J Am Coll Cardiol. 75: 1281-1295Pfeffer M.A. Shah A.M. Borlaug B.A.

Heart failure with preserved ejection fraction in perspective.

Circ Res. 124: 1598-1617Smiseth O.A. Morris D.A. Cardim N. et al.

Multimodality imaging in patients with heart failure and preserved ejection fraction: an expert consensus document of the European Association of Cardiovascular Imaging.

Eur Heart J Cardiovasc Imaging. 23: e34-e61Yancy C.W. Jessup M. Bozkurt B. et al.

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

Circulation. 128 ()Pieske B. Tschöpe C. de Boer R.A. et al.

How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).

Eur Heart J. 40: 3297-3317Reddy Y.N.V. Carter R.E. Obokata M. et al.

A Simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction.

Circulation. 138: 861-870Sepehrvand N. Alemayehu W. Dyck G.J.B. et al.

External validation of the H(2)F-PEF model in diagnosing patients with heart failure and preserved ejection fraction.

Circulation. 139: 2377-2379Lang R.M. Badano L.P. Mor-Avi V. et al.

Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

J Am Soc Echocardiogr. 28: 1-39.e14Zile M.R. Gottdiener J.S. Hetzel S.J. et al.

Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction.

Circulation. 124: 2491-2501Lam C.S. Roger V.L. Rodeheffer R.J. et al.

Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota.

Circulation. 115: 1982-1990Morris D.A. Ma X.X. Belyavskiy E. et al.

Left ventricular longitudinal systolic function analysed by 2D speckle-tracking echocardiography in heart failure with preserved ejection fraction: a meta-analysis.

Open Heart. 4: e000630Wang J. Khoury D.S. Yue Y. et al.

Preserved left ventricular twist and circumferential deformation, but depressed longitudinal and radial deformation in patients with diastolic heart failure.

Eur Heart J. 29: 1283-1289Lumens J. Delhaas T. Arts T. et al.

Impaired subendocardial contractile myofiber function in asymptomatic aged humans, as detected using MRI.

Am J Physiol Heart Circ Physiol. 291: H1573-H1579Martinez D.A. Guhl D.J. Stanley W.C. et al.

Extracellular matrix maturation in the left ventricle of normal and diabetic swine.

Diabetes Res Clin Pract. 59: 1-9Nagueh S.F. Smiseth O.A. Appleton C.P. et al.

Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the american society of echocardiography and the european association of cardiovascular imaging.

J Am Soc Echocardiogr. 29: 277-314

Left atrial size and function: role in prognosis.

J Am Coll Cardiol. 63: 493-505Inoue K. Khan F.H. Remme E.W. et al.

Determinants of left atrial reservoir and pump strain and use of atrial strain for evaluation of left ventricular filling pressure.

Eur Heart J Cardiovasc Imaging. 23: 61-70Morris D.A. Belyavskiy E. Aravind-Kumar R. et al.

Potential usefulness and clinical relevance of adding left atrial strain to left atrial volume index in the detection of left ventricular diastolic dysfunction.

JACC Cardiovasc Imaging. 11: 1405-1415Lam C.S. Roger V.L. Rodeheffer R.J. et al.

Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study.

J Am Coll Cardiol. 53: 1119-1126Andersen O.S. Smiseth O.A. Dokainish H. et al.

Estimating left ventricular filling pressure by echocardiography.

J Am Coll Cardiol. 69: 1937-1948Lancellotti P. Galderisi M. Edvardsen T. et al.

Echo-Doppler estimation of left ventricular filling pressure: results of the multicentre EACVI Euro-Filling study.

Eur Heart J Cardiovasc Imaging. 18: 961-968Williams B. Mancia G. Spiering W. et al.

2018 ESC/ESH Guidelines for the management of arterial hypertension.

Eur Heart J. 39: 3021-3104Olsen F.J. Møgelvang R. Modin D. et al.

Association between isometric and allometric height-indexed left atrial size and atrial fibrillation.

J Am Soc Echocardiogr. 35: 141-150.e4Nagueh S.F. Chang S.M. Nabi F. et al.

Cardiac imaging in patients with heart failure and preserved ejection fraction.

Circ Cardiovasc Imaging. 10: e006547Obokata M. Kane G.C. Reddy Y.N. et al.

Role of diastolic stress testing in the evaluation for heart failure with preserved ejection fraction: a simultaneous invasive-echocardiographic study.

Circulation. 135: 825-838Hwang S.J. Melenovsky V. Borlaug B.A.

Implications of coronary artery disease in heart failure with preserved ejection fraction.

J Am Coll Cardiol. 63: 2817-2827Rush C.J. Berry C. Oldroyd K.G. et al.

Prevalence of coronary artery disease and coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction.

JAMA Cardiol. 6: 1130-1143Obokata M. Reddy Y.N.V. Melenovsky V. et al.

Myocardial injury and cardiac reserve in patients with heart failure and preserved ejection fraction.

J Am Coll Cardiol. 72: 29-40Bravo P.E. Di Carli M.F. Dorbala S.

Role of PET to evaluate coronary microvascular dysfunction in non-ischemic cardiomyopathies.

Heart Fail Rev. 22: 455-464Jaarsma C. Leiner T. Bekkers S.C. et al.

Diagnostic performance of noninvasive myocardial perfusion imaging using single-photon emission computed tomography, cardiac magnetic resonance, and positron emission tomography imaging for the detection of obstructive coronary artery disease: a meta-analysis.

J Am Coll Cardiol. 59: 1719-1728Taqueti V.R. Solomon S.D. Shah A.M. et al.

Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction.

Eur Heart J. 39: 840-849Chirinos J.A. Segers P. Hughes T. et al.

Large-artery stiffness in Health and disease: JACC state-of-the-art review.

J Am Coll Cardiol. 74: 1237-1263Maron B.J. Desai M.Y. Nishimura R.A. et al.

Diagnosis and evaluation of hypertrophic cardiomyopathy: JACC state-of-the-art review.

J Am Coll Cardiol. 79: 372-389Rowin E.J. Maron B.J. Maron M.S.

The hypertrophic cardiomyopathy phenotype viewed through the prism of multimodality imaging: clinical and etiologic implications.

JACC Cardiovasc Imaging. 13: 2002-2016Chan R.H. Maron B.J. Olivotto I. et al.

Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.

Circulation. 130: 484-495

Multimodality imaging for the diagnosis of infiltrative cardiomyopathies.

Heart. 108: 98-104Seward J.B. Casaclang-Verzosa G.

Infiltrative cardiovascular diseases: cardiomyopathies that look alike.

J Am Coll Cardiol. 55: 1769-1779Nochioka K. Quarta C.C. Claggett B. et al.

Left atrial structure and function in cardiac amyloidosis.

Eur Heart J Cardiovasc Imaging. 18: 1128-1137Dorbala S. Ando Y. Bokhari S. et al.

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.

J Nucl Cardiol. 26: 2065-2123Phelan D. Collier P. Thavendiranathan P. et al.

Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis.

Heart. 98: 1442-1448Fontana M. Chung R. Hawkins P.N. et al.

Cardiovascular magnetic resonance for amyloidosis.

Heart Fail Rev. 20: 133-144Baggiano A. Boldrini M. Martinez-Naharro A. et al.

Noncontrast magnetic resonance for the diagnosis of cardiac amyloidosis.

JACC Cardiovasc Imaging. 13: 69-80Fontana M. Banypersad S.M. Treibel T.A. et al.

Differential myocyte responses in patients with cardiac transthyretin amyloidosis and light-chain amyloidosis: a cardiac mr imaging study.

Radiology. 277: 388-397Kittleson M.M. Maurer M.S. Ambardekar A.V. et al.

Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the american heart association.

Circulation. 142: e7-e22Perry R. Shah R. Saiedi M. et al.

The role of cardiac imaging in the diagnosis and management of anderson-fabry disease.

JACC Cardiovasc Imaging. 12: 1230-1242Linhart A. Kampmann C. Zamorano J.L. et al.

Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey.

Eur Heart J. 28: 1228-1235Kozor R. Grieve S.M. Tchan M.C. et al.

Cardiac involvement in genotype-positive Fabry disease patients assessed by cardiovascular MR.

Heart. 102: 298-302Thompson R.B. Chow K. Khan A. et al.

T₁ mapping with cardiovascular MRI is highly sensitive for Fabry disease independent of hypertrophy and sex.

Circ Cardiovasc Imaging. 6: 637-645Augusto J.B. Nordin S. Vijapurapu R. et al.

Myocardial edema, myocyte injury, and disease severity in fabry disease.

Circ Cardiovasc Imaging. 13: e010171Nappi C. Altiero M. Imbriaco M. et al.

First experience of simultaneous PET/MRI for the early detection of cardiac involvement in patients with Anderson-Fabry disease.

Eur J Nucl Med Mol Imaging. 42: 1025-1031Waldek S. Patel M.R. Banikazemi M. et al.

Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry.

Genet Med. 11: 790-796

Fabry disease and its cardiac involvement.

J Gen Fam Med. 18: 225-229Nakao S. Takenaka T. Maeda M. et al.

An atypical variant of Fabry's disease in men with left ventricular hypertrophy.

N Engl J Med. 333: 288-293Trivieri M.G. Spagnolo P. Birnie D. et al.

Challenges in cardiac and pulmonary sarcoidosis: JACC state-of-the-art review.

J Am Coll Cardiol. 76: 1878-1901Slart R. Glaudemans A. Lancellotti P. et al.

A joint procedural position statement on imaging in cardiac sarcoidosis: from the cardiovascular and inflammation & infection committees of the European association of nuclear medicine, the European association of cardiovascular imaging, and the American society of nuclear cardiology.

J Nucl Cardiol. 25: 298-319Anderson L.J. Holden S. Davis B. et al.

Cardiovascular T2-star (T2∗) magnetic resonance for the early diagnosis of myocardial iron overload.

Eur Heart J. 22: 2171-2179Kirk P. Roughton M. Porter J.B. et al.

Cardiac T2∗ magnetic resonance for prediction of cardiac complications in thalassemia major.

Circulation. 120: 1961-1968Torlasco C. Cassinerio E. Roghi A. et al.

Role of T1 mapping as a complementary tool to T2∗ for non-invasive cardiac iron overload assessment.

PLoS One. 13: e0192890Sweeney M. Corden B. Cook S.A.

Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?.

EMBO Mol Med. 12: e10865Mascherbauer J. Marzluf B.A. Tufaro C. et al.

Cardiac magnetic resonance postcontrast T1 time is associated with outcome in patients with heart failure and preserved ejection fraction.

Circ Cardiovasc Imaging. 6: 1056-1065Duca F. Kammerlander A.A. Zotter-Tufaro C. et al.

Interstitial fibrosis, functional status, and outcomes in heart failure with preserved ejection fraction: insights from a prospective cardiac magnetic resonance imaging study.

Circ Cardiovasc Imaging. 9: e005277Su M.Y. Lin L.Y. Tseng Y.H. et al.

CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF.

JACC Cardiovasc Imaging. 7: 991-997Assadi H. Jones R. Swift A.J. et al.

Cardiac MRI for the prognostication of heart failure with preserved ejection fraction: a systematic review and meta-analysis.

Magn Reson Imaging. 76: 116-122Nacif M.S. Liu Y. Yao J. et al.

3D left ventricular extracellular volume fraction by low-radiation dose cardiac CT: assessment of interstitial myocardial fibrosis.

J Cardiovasc Comput Tomogr. 7: 51-57Hahn V.S. Yanek L.R. Vaishnav J. et al.

Endomyocardial biopsy characterization of heart failure with preserved ejection fraction and prevalence of cardiac amyloidosis.

JACC Heart Fail. 8: 712-724Lewis G.A. Dodd S. Clayton D. et al.

Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial.

Nat Med. 27: 1477-1482Chirinos J.A. Kips J.G. Jacobs Jr., D.R. et al.

Arterial wave reflections and incident cardiovascular events and heart failure: MESA (Multiethnic Study of Atherosclerosis).

J Am Coll Cardiol. 60: 2170-2177Karagodin I. Aba-Omer O. Sparapani R. et al.

Aortic stiffening precedes onset of heart failure with preserved ejection fraction in patients with asymptomatic diastolic dysfunction.

BMC Cardiovasc Disord. 17: 62Chi C. Liu Y. Xu Y. et al.

Association between arterial stiffness and heart failure with preserved ejection fraction.

Front Cardiovasc Med. 8: 707162

Noninvasive evaluation of left ventricular afterload: part 1: pressure and flow measurements and basic principles of wave conduction and reflection.

Hypertension. 56: 555-562Segers P. Rietzschel E.R. Chirinos J.A.

How to measure arterial stiffness in humans.

Arterioscler Thromb Vasc Biol. 40: 1034-1043

Echocardiographic assessment of large artery stiffness.

J Am Soc Echocardiogr. 29: 1117-1121Matsushita K. Ding N. Kim E.D. et al.

Cardio-ankle vascular index and cardiovascular disease: systematic review and meta-analysis of prospective and cross-sectional studies.

J Clin Hypertens (Greenwich). 21: 16-24Budoff M.J. Alpert B. Chirinos J.A. et al.

Clinical applications measuring arterial stiffness: an expert consensus for the application of cardio-ankle vascular index (CAVI).

Am J Hypertens. 35: 441-453Spronck B. Obeid M.J. Paravathaneni M. et al.

Predictive ability of pressure-corrected arterial stiffness indices: comparison of pulse wave velocity, cardio-ankle vascular index (CAVI), and CAVI0.

Am J Hypertens. 35: 272-280

Arterial wall stiffness: basic principles and methods of measurement in vivo.

Elsevier/Academic Press, London, UK

Pulsatile arterial haemodynamics in heart failure.

Eur Heart J. 39: 3847-3854Ikonomidis I. Aboyans V. Blacher J. et al.

The role of ventricular-arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions. A consensus document of the European Society of Cardiology Working Group on Aorta & Peripheral Vascular Diseases, European Association of Cardiovascular Imaging, and Heart Failure Association.

Eur J Heart Fail. 21: 402-424Chirinos J.A. Sweitzer N.

Ventricular-arterial coupling in chronic heart failure.

Card Fail Rev. 3: 12-18

Ventricular-arterial coupling: invasive and non-invasive assessment.

Artery Res. 7

Essential principles of pulsatile pressure-flow relations in the arterial tree.

in: Chirinos J.A. Textbook of arterial stiffness and pulsatile hemodynamics in Health and disease. Academic Press/Elsevier, London, UK: 49-65

Mitchell GF. Assessment of ventricular arterial interactions via arterial pressure-flow relations in humans. London. UK: Academic Press/Elsevier.

Selvaraj S. Kim J. Ansari B.A. et al.

Body composition, natriuretic peptides, and adverse outcomes in heart failure with preserved and reduced ejection fraction.

JACC Cardiovasc Imaging. 14: 203-215

The HFpEF obesity phenotype: the elephant in the room.

J Am Coll Cardiol. 68: 200-203Obokata M. Reddy Y.N.V. Pislaru S.V. et al.

Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction.

Circulation. 136: 6-19Koepp K.E. Obokata M. Reddy Y.N.V. et al.

Hemodynamic and functional impact of epicardial adipose tissue in heart failure with preserved ejection fraction.

JACC Heart Fail. 8: 657-666Cruz-Jentoft A.J. Bahat G. Bauer J. et al.

Sarcopenia: revised European consensus on definition and diagnosis.

Age Ageing. 48: 16-31Haykowsky M.J. Kouba E.J. Brubaker P.H. et al.

Skeletal muscle composition and its relation to exercise intolerance in older patients with heart failure and preserved ejection fraction.

Am J Cardiol. 113: 1211-1216Kitzman D.W. Nicklas B. Kraus W.E. et al.

Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction.

Am J Physiol Heart Circ Physiol. 306: H1364-H1370Kogan F. Hariharan H. Reddy R.

Chemical exchange saturation transfer (CEST) imaging: description of technique and potential clinical applications.

Curr Radiol Rep. 1: 102-114Kumar A.A. Kelly D.P. Chirinos J.A.

Mitochondrial dysfunction in heart failure with preserved ejection fraction.

Circulation. 139: 1435-1450Zamani P. Proto E.A. Wilson N. et al.

Multimodality assessment of heart failure with preserved ejection fraction skeletal muscle reveals differences in the machinery of energy fuel metabolism.

ESC Heart Fail. 8: 2698-2712Kumar A. Ansari B.A. Kim J. et al.

Axial muscle size as a strong predictor of death in subjects with and without heart failure.

J Am Heart Assoc. 8: e010554Salah H.M. Pandey A. Soloveva A. et al.

Relationship of nonalcoholic fatty liver disease and heart failure with preserved ejection fraction.

JACC Basic Transl Sci. 6: 918-932

Hepatic venous compliance and role of liver as a blood reservoir.

Am J Physiol. 231: 292-295Fudim M. Sobotka P.A. Dunlap M.E.

Extracardiac abnormalities of preload reserve: mechanisms underlying exercise limitation in heart failure with preserved ejection fraction, autonomic dysfunction, and liver disease.

Circ Heart Fail. 14: e007308

Liver ultrasound elastography: more than staging the disease.

World J Hepatol. 7: 1595-1600Barr R.G. Wilson S.R. Rubens D. et al.

Update to the society of radiologists in ultrasound liver elastography consensus statement.

Radiology. 296: 263-274Guglielmo F.F. Venkatesh S.K. Mitchell D.G.

Liver MR elastography technique and image interpretation: pearls and pitfalls.

Radiographics. 39: 1983-2002van de Wouw J. Broekhuizen M. Sorop O. et al.

Chronic kidney disease as a risk factor for heart failure with preserved ejection fraction: a focus on microcirculatory factors and therapeutic targets.

Front Physiol. 10: 1108Iida N. Seo Y. Sai S. et al.

Clinical implications of intrarenal hemodynamic evaluation by Doppler ultrasonography in heart failure.

JACC Heart Fail. 4: 674-682de la Espriella-Juan R. Núñez E. Miñana G. et al.

Intrarenal venous flow in cardiorenal syndrome: a shining light into the darkness.

ESC Heart Fail. 5: 1173-1175Puzzovivo A. Monitillo F. Guida P. et al.

Renal venous pattern: a new parameter for predicting prognosis in heart failure outpatients.

J Cardiovasc Dev Dis. 5Ennezat P.V. Maréchaux S. Six-Carpentier M. et al.

Renal resistance index and its prognostic significance in patients with heart failure with preserved ejection fraction.

Nephrol Dial Transpl. 26: 3908-3913Wu J. Shi Z. Zhang Y. et al.

Native T1 mapping in assessing kidney fibrosis for patients with chronic glomerulonephritis.

Front Med (Lausanne). 8: 772326